author-photo

Linda S. Steelman

East Carolina University

157

Papers

12696

Citations

Citation Trend

Filter By

Papers (118) Sort By

Journal Conference Others

Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53.

2021 Advances in biological regulation
Show All
- Source
- Cite
- Save
Citations (1)
New landscapes and horizons in hepatocellular carcinoma therapy

2020
Show All
- Source
- Cite
- Save
Citations (18)
Therapeutic resistance in breast cancer cells can result from deregulated EGFR signaling.

2020 Advances in biological regulation
Show All
- Source
- Cite
- Save
Citations (5)
Cancer therapy and treatments during COVID-19 era

2020 Advances in biological regulation
Show All
- Source
- Cite
- Save
Citations (13)
Targeting GSK3 and Associated Signaling Pathways Involved in Cancer.

2020 Cells
Show All
- Source
- Cite
- Save
Citations (47)
Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines.

2020
Show All
- Source
- Cite
- Save
Citations (7)
GSK-3 and miRs: Master regulators of therapeutic sensitivity of cancer cells.

2020 Biochimica et Biophysica Acta
Show All
- Source
- Cite
- Save
Citations (4)
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals

2019 Advances in biological regulation
Show All
- Source
- Cite
- Save
Citations (5)
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells

2019 Advances in biological regulation
Show All
- Source
- Cite
- Save
Citations (12)
RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma

2019 Expert Opinion on Therapeutic Targets
Show All
- Source
- Cite
- Save
Citations (18)